Serum FGF21 levels are significantly increased in individuals with T2DM and obesity, which can be deleterious for sarcopenic individuals with physical frailty (Zhang et al., 2008; Chen et al., 2011; Xiao et al., 2012). Here, FGF21 is linked to Obesity.